Insights - Fennec Pharmaceuticals (FENC:NASDAQ) (FRX.TO:TSX) released the results of its long anticipated Phase 3 study. Interim data showed Fennec’s drug, sodium thiosulfate (“STS”) significantly reduces chemotherapy … Continue Reading
Research - Paratek Pharmaceuticals (PRTK) released their top-line, OASIS-2 results after the bell yesterday, comparing oral omadacycline to linezolid in ABSSSI infections. Omadacycline achieved all primary and … Continue Reading
You're all done! We've sent you a confirmation email that includes a verification link. To access the page you're interested in, check your email inbox(including spam folder) and click the verification link.